Co-Authors
This is a "connection" page, showing publications co-authored by Eldad Hod and Zachary Bitan.
Connection Strength
0.227
-
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19. J Clin Invest. 2021 07 01; 131(13).
Score: 0.060
-
Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat Immunol. 2021 01; 22(1):25-31.
Score: 0.057
-
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 06 16; 21(1):536.
Score: 0.055
-
Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 06 08; 21(1):499.
Score: 0.055